"The ongoing gutting of the FDA is likely to cause American deaths," said the CEO of one medical device developer.

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

To accelerate potential completion of ongoing partnership restructuring negotiations, Orchestra BioMed and Terumo have elected to enter a mediation process and are currently working on a procedural ...

The Food and Drug Administration has identified a Class I recall of Medtronic Aortic Root Cannulas due to a risk of ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Mastercard Inc. (MA), Medtronic plc ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Medtronic (MDT) shares snapped seven straight days of losses as the stock closed xx% higher, at $xx on Thursday. The medical ...

Some U.S. health regulators who review medical devices and tobacco products for safety and efficacy are struggling to meet ...

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Twenty-eight years later, as a political science professor emeritus at Stanford, Krehbiel just became the first person in the ...

From new partnerships to product launches, here are 12 key developments in orthobiologics during the first quarter of 2025. 1. Medtronic and Kuros Biosciences signed a strategic agreement to support ...